Calgary, Alberta, Canada – April 23, 2025 –TheNewswire -Voyageur Pharmaceuticals Ltd. (VM:CA) (OTC Pink:VYYRF) ("Voyageur" or the "Company") a radiology contrast media company focused on vertical ...
CALGARY, ALBERTA - June 4, 2025 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company"), a radiology contrast media company focused on vertical ...
Calgary, Alberta, Canada – TheNewswire - January 13, 2025 - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") is pleased to announce that it has begun human ...
CALGARY, Canada - (NewMediaWire) - May 28, 2024 - Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) ("Voyageur" or the "Company") proudly announces its first international distribution agreement ...
Bracco Diagnostics announced that the Food and Drug Administration (FDA) has approved E-Z-HD (barium sulfate) for oral suspension for use in double-contrast radiographic examinations of the esophagus, ...
Bracco Diagnostics announced that the FDA has approved a New Drug Application (NDA) for READI-CAT 2 and READI-CAT 2 SMOOTHIE (barium sulfate) oral suspension for use in computed tomography (CT) of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results